CIK 1802528
Fairmount Funds Management LLC
Institutional 13F holdings & portfolio
Holdings
13
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 1–13 of 13
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| COGT | COGENT BIOSCIENCES INC | 9.0M | $1M+ | SH |
| APGE | APOGEE THERAPEUTICS INC | 2.0M | $1M+ | SH |
| SYRE | SPYRE THERAPEUTICS INC | 4.0M | $1M+ | SH |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3.9M | $1M+ | SH |
| ORKA | ORUKA THERAPEUTICS INC | 3.7M | $1M+ | SH |
| DNTH | DIANTHUS THERAPEUTICS INC | 2.1M | $1M+ | SH |
| ZBIO | ZENAS BIOPHARMA INC | 2.2M | $1M+ | SH |
| NUVL | NUVALENT INC | 728K | $1M+ | SH |
| JBIO | JADE BIOSCIENCES INC | 4.6M | $1M+ | SH |
| ELVN | ENLIVEN THERAPEUTICS INC | 3.7M | $1M+ | SH |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 1.3M | $1M+ | SH |
| CBIO | CRESCENT BIOPHARMA INC. | 2.7M | $1M+ | SH |
| IKT | INHIBIKASE THERAPEUTICS INC | 8.6M | $1M+ | SH |